Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sickle cell disease
Payers
Insurers question cell and gene therapy costs as new model nears
Health plans and employers view gene therapy affordability as a challenge, as the CMS rolls out a sickle cell model to improve cost outcomes.
Noah Tong
May 5, 2025 4:00pm
CMS names two drug manufacturers for cell and gene therapy model
Dec 4, 2024 10:19am
Walgreens' pharmacy unit to offer gene and cell therapy services
Apr 25, 2024 1:00am
CMS: Cell and gene therapy model to focus first on sickle cell
Jan 31, 2024 7:00am
